KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) EPS (Basic) (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of EPS (Basic) data on record, last reported at $0.11 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 102.76% year-over-year to $0.11; the TTM value through Dec 2025 reached $1.81, down 22.65%, while the annual FY2025 figure was $1.81, 22.65% down from the prior year.
  • EPS (Basic) reached $0.11 in Q4 2025 per EW's latest filing, down from $0.5 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $5.14 in Q3 2024 and bottomed at -$3.99 in Q4 2024.
  • Average EPS (Basic) over 5 years is $0.54, with a median of $0.55 recorded in 2021.
  • The widest YoY moves for EPS (Basic): up 834.55% in 2024, down 754.1% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $0.53 in 2021, then plummeted by 37.74% to $0.33 in 2022, then surged by 84.85% to $0.61 in 2023, then plummeted by 754.1% to -$3.99 in 2024, then soared by 102.76% to $0.11 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $0.11 in Q4 2025, $0.5 in Q3 2025, and $0.59 in Q2 2025.